Activation of estrogen receptor-mediated gene transcription by IGF-I in human breast cancer cells

Journal of Endocrinology

Volumn 152, Issue 1, 1997, Pages 39-47

  Lee, A V ^a   Weng, C N ^a   Jackson, J G ^a   Yee, D ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DACTINOMYCIN; ESTROGEN RECEPTOR; SOMATOMEDIN C; TAMOXIFEN;

ARTICLE; BREAST CANCER; CANCER CELL; CELL GROWTH; CELL PROLIFERATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; RECEPTOR BINDING; RECEPTOR GENE; SIGNAL TRANSDUCTION;

EID: 0031031824     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1520039     Document Type: Article

References (42)

1. Aronica SM & Katzenellenbogen BS 1993 Stimulation of estrogen receptor-mediated transcription and alteration in the phosphorylation state ot the rat uterine estrogen receptor by estrogen, cyclic adenosine monophosphate, and insulin-like growth factor-I. Molecular Endocrinology 7 743-752.
2. Burgard J-L & Baserga R 1996 Intracellular transactivation of the insulin-like growth factor I receptor by an epidermal growth factor receptor. Experimental Cell Research 223 412-419.
3. Cavailles V, Dauvois S, L'Horset F, Lopez G, Hoare S, Kushner P & Parker M 1995 Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. EMBO Journal 14 3741-3751.
4. Chen JD & Evans RM 1995 A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377 371-374.
5. Cho H, Aronica S & Katzenellenbogen BS 1994 Regulation of progesterone receptor gene expression in MCF-7 breast cancer cells: A comparison of the effects of cyclic adenosine 3′-5′-monophosphate, estradiol, insulin-like growth factor-I and serum factors. Endocrinology 134 658-664.
6. Confort C, Rochefort H & Vignon F 1995 Insulin-like growth factors (IGFs) stimulate the release of α1-antichymotrypsin and soluble IGF-II/mannose-6-phosphate receptor from MCF-7 breast cancer cells. Endocrinology 136 3759-3766.
7. De Mellow JS & Baxter RC 1988 Growth hormone-dependent insulin-like growth factor (IGF) binding protein both inhibits and potentiates IGF-stimulated DNA synthesis in human skin fibroblasts. Biochemical and Biophysical Research Communications 156 199-204.
8. Figueroa JA, Sharma J, Jackson JG, McDermott MJ, Hilsenbeck SG & Yee D 1993 Recombinant insulin-like growth factor binding protein 1 inhibits IGF-I, serum and estrogen dependent growth of MCF-7 human breast cancer cells. Journal of Cellular Physiology 157 229-236.
9. Freiss G, Rochefort H & Vignon F 1990 Mechanisms of 4-hydroxytamoxifen anti-growth factor activity in breast cancer cells: Alterations of growth factor receptor binding sites and tyrosine kinase activity. Biochemical and Biophysical Research Communications 3 919-926.
10. Green S & Chambon P 1991 The oestrogen receptor: From perception to mechanism. In Nuclear Hormone Receptors, pp 15-38. Ed M Parker. London: Academic Press.
11. Huynh H, Yang X & Pollak M 1996 Estradiol and antiestrogens regulate a growth inhibitory insulin-like growth factor binding protein 3 autocrine loop in human breast cancer cells. Journal of Biological Chemistry 271 1016-1021.
12. Ignar-Trowbridge DM, Pimentel M, Parker MG, McLachlan JA & Korach KS 1996 Peptide growth factors cross-talk with the estrogen receptor requires the A/B domain and occurs independently of protein kinase C or estradiol. Endocrinology 137 1735-1744.
13. Jensen EV 1991 Overview of the nuclear receptor family. In Nuclear Hormone Receptors, pp 1-13. Ed M Parker. London: Academic Press.
14. Kato S, Endoh H, Masuhiro Y, Kitamoto T, Uchiyama S, Sasaki H, Masushige S, Gotoh Y, Nishida E, Kawashima H, Metzger D & Chambon P 1995 Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 270 1491-1494.
15. Katzenellenbogen B & Norman MJ 1990 Multihormonal regulation of the progesterone receptor in MCF-7 human breast cancer cells: Interrelationships among insulin/insulin-like growth faetor-I, serum, and estrogen. Endocrinology 126 891-898.
16. Kleinman D, Karas M, Danilenko M, Arbeli A, Roberts CT, LeRoith D, Levy J & Sharoni Y 1996 Stimulation of endometrial cancer cell growth by tamoxifen is associated with increased insulin-like growth factor (IGF)-I induced tyrosine phosphorylation and reduction in IGF binding proteins. Endocrinology 137 1089-1095.
17. Lee AV & Yee D 1995 Insulin-like growth factors and breast cancer. Biomedicine and Pharmacotherapy 49 415-421.
18. Lee AV, Darbre P & King RJB 1994 Processing of insulin-like growth factor-11 (IGF-II) by human breast cancer cells. Molecular and Cellular Endocrinology 99 211-220.
19. Ma ZQ, Santagati S, Patrone G, Pollio G, Vegeto E & Maggi A 1994 Insulin-like growth factors activate estrogen receptor to control the growth and differentiation of the human neuroblastoma cell line SK-ER3. Molecular Endocrinology 8 910-918.
20. McGuire WJ, Jackson JG, Figueroa JA, Shimasaki SA, Powell DR & Yee D 1992 Regulation of insulin-like growth factor-binding protein (IGFBP) expression by breast cancer cells: Use of IGFBP-1 as an inhibitor of insulin-like growth factor action. Journal of the National Cancer Institute 84 1336-1341.
21. Mathieu M, Vignon F, Capony F & Rochefort H 1991 Estradiol down-regulates the mannose-6-phosphate/insulin-like growth factor-II receptor gene and induces cathepsin-D in breast cancer cells: A receptor saturation mechanism to increase the secretion of lysosomal proenzymes. Molecular Endocrinology 5 815-823.
22. Myers MG, Sun XJ & White MF 1994 The IRS signaling system. Trends in Biochemical Sciences 19 289-293.
23. Newton CJ, Buric R, Trapp T, Brockmeier S, Pagotto U & Stalla G 1994 The unliganded estrogen receptor (ER) transduces growth factor signals. Journal of Steroid Biochemistry and Molecular Biology 48 481-486.
24. Osborne CK & Arteaga CL 1990 Autocrine and paracrine growth regulation of breast cancer: clinical implications. Breast Cancer Research and Treatment 15 3-11.
25. Osborne CK, Hobbs K & Trent JM 1987 Biological differences among MCF-7 human breast cancer cell lines from different laboratories. Breast Cancer Research and Treatment 9 111-121.
26. Patrone C, Ma ZQ, Pollio G, Agrati P, Parker MG & Maggi A 1996 Cross-coupling between insulin and estrogen receptor in human neuroblastoma cells. Molecular Endocrinology 10 499-507.
27. Pause A, Belsham GJ, Gingras A-C, Donze O, Lin T-A, Lawrence JC & Sonenberg N 1994 Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 5′-cap function. Nature 371 762-767.
28. Pollack MN, Huynh HT & Lefebvre SP 1992 Tamoxifen reduces serum insulin-like growth factor I (IGF-I). Breast Cancer Research and Treatment 22 91-100.
29. Rajkumar K, Dheen T, Krsek M & Murphy LJ 1996 Impaired estrogen action in the uterus of insulin-like growth factor binding protein-1 transgenic mice. Endocrinology 137 1258-1264.
30. Rouet P, Ranguenez G & Salier J-P 1992 Optimized assays for quantifying transient expression of co-transfected β-galactosidase and CAT-reporter genes. Bio Techniques 13 700-701.
31. H. Cancer Research 50 67-71.
32. Steele-Perkins G, Turner J, Edman JC, Hari J, Pierce SB, Stover C, Rutter WJ & Roth RA 1988 Expression and characterisation of a functional human insulin-like growth factor receptor. Journal of Biological Chemistry 263 11486-11492.
33. Stewart A, Westley B & May F 1992 Modulation of the proliferative response of breast cancer cells to growth factors by oestrogen. British Journal of Cancer 66 640-648.
34. Twentyman PR & Luscombe M 1987 A study of some variables in a tetrazolium dye (MTT) based assay for cell growth and chemosensitivity. British Journal of Cancer 56 279-285.
35. Ullrich A & Schlessinger J 1990 Signal transduction by receptors with tyrosine kinase activity. Cell 61 203-212.
36. Van den Burg B, Rutterman GR, Blankstein MA, de Laat SW & van Zoelen EJJ 1988 Mitogenic stimulation of human breast cancer cells in a growth factor defined medium: synergistic action of insulin and estrogen. Journal of Cellular Physiology 123 101-108.
37. Vignon F, Bouton M-M & Rochefort H 1988 Antiestrogens inhibit the mitogenic effect of growth factors on breast cancer cells in the total absence of estrogens. Biochemical and Biophysical Research Communications 146 1502-1508.
38. Westley BR & May FEB 1994 Role of insulin-like growth factors in steroid modulated proliferation. Journal of Steroid Biochemistry and Molecular Biology 51 1-9.
39. Yee D (Ed) 1992 Insulin-like growth factors in human breast cancer. Breast Cancer Research and Treatment 22 1-106.
40. Yee D, Cullen K, Paik S, Perdue J, Hampton B, Schwartz A, Lippman M & Rosen N 1988 Insulin-like growth factor II mRNA expression in human breast cancer. Cancer Research 48 6691-6696.
41. Yee D, Favoni R, Lippman M & Powell D 1991 Identification of insulin-like growth factor binding proteins in breast cancer cells. Breast Cancer Research and Treatment 18 3-10.
42. Yee D, Jackson JG, Kozelsky TW & Figueroa JA 1994 Insulin-like growth factor binding protein 1 expression inhibits insulin-like growth factor I action in MCF-7 cells. Cell Growth and Differentiation 5 73-77.